CH can occur with mutations in myeloid neoplasm‐associated genes at a VAF ≥2%, or with non‐MDS defining cytogenetic alterations, in either case termed CH of indeterminate potential31, 32 (CHIP). The gene discussed is STUB1; the disease is myelodysplastic syndrome.